Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$53.58 - $57.02 $96,444 - $102,636
-1,800 Reduced 2.47%
71,200 $4 Million
Q1 2024

Apr 29, 2024

BUY
$42.56 - $59.82 $3.11 Million - $4.37 Million
73,000 New
73,000 $4.12 Million
Q4 2020

Feb 09, 2021

SELL
$85.88 - $105.36 $11.4 Million - $14 Million
-133,000 Closed
0 $0
Q2 2020

Jul 23, 2020

BUY
$48.02 - $79.04 $6.39 Million - $10.5 Million
133,000 New
133,000 $9.75 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mn Services Vermogensbeheer B.V. Portfolio

Follow Mn Services Vermogensbeheer B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.